NantHealth (NH) Tops Q2 EPS by 5c, Revenues Beat

NantHealth (NASDAQ: NH) reported Q2 EPS of ($0.04), $0.05 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $25.7 million versus the consensus estimate of $23.77 million.

• Q2 Financial Highlights:
  • Fourth consecutive quarter of total revenue growth
  • Total revenue was $25.7 million, up 17% from Q2 2018
  • SaaS revenue of $18.3 million, rose 13% from Q2 2018 and 3% sequentially
  • Gross profit was $15.9 million, compared with $11.5 million in Q2 2018
  • Gross margin increased to 62% from 52% in Q2 2018
• Software and Service business continued positive momentum in 1H 2019

“Our 2019 second quarter represents the fourth consecutive quarter of total revenue growth,” said Bob Petrou, Chief Financial Officer of NantHealth. “We generated strong topline growth and substantial gross margin improvement, which was largely driven by continued positive momentum in our Software and SaaS business, and the continuation of cost management throughout the company.”

For earnings history and earnings-related data on NantHealth (NH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Evogene chairman to address dissident shareholders on results call
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c